Kin Man Au

1.0k total citations
24 papers, 858 citations indexed

About

Kin Man Au is a scholar working on Oncology, Biomedical Engineering and Immunology. According to data from OpenAlex, Kin Man Au has authored 24 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Biomedical Engineering and 6 papers in Immunology. Recurrent topics in Kin Man Au's work include CAR-T cell therapy research (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Photoacoustic and Ultrasonic Imaging (4 papers). Kin Man Au is often cited by papers focused on CAR-T cell therapy research (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Photoacoustic and Ultrasonic Imaging (4 papers). Kin Man Au collaborates with scholars based in United States, China and United Kingdom. Kin Man Au's co-authors include Andrew Z. Wang, Steven P. Armes, Steven Park, Xi Tian, Yuanzeng Min, Stephen J. Matcher, Zenghai Lu, Joseph M. Caster, Kyle Wagner and Longzhen Zhang and has published in prestigious journals such as Advanced Materials, ACS Nano and Biomaterials.

In The Last Decade

Kin Man Au

23 papers receiving 853 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kin Man Au United States 16 366 255 238 210 151 24 858
Jingxing Si China 14 402 1.1× 292 1.1× 297 1.2× 121 0.6× 93 0.6× 31 856
Jueun Jeon South Korea 18 482 1.3× 316 1.2× 269 1.1× 91 0.4× 76 0.5× 27 913
Dennis Huang United States 10 455 1.2× 303 1.2× 244 1.0× 133 0.6× 117 0.8× 14 763
Soyoung Son South Korea 17 613 1.7× 537 2.1× 451 1.9× 114 0.5× 166 1.1× 23 1.2k
Chih‐Sheng Chiang Taiwan 15 609 1.7× 486 1.9× 231 1.0× 106 0.5× 139 0.9× 20 961
Lingxi Xing China 15 566 1.5× 345 1.4× 270 1.1× 130 0.6× 75 0.5× 19 945
Pablo Scodeller Estonia 20 383 1.0× 344 1.3× 699 2.9× 197 0.9× 291 1.9× 32 1.5k
Jinxing Xia China 14 500 1.4× 322 1.3× 415 1.7× 290 1.4× 315 2.1× 28 1.1k
Yaohua Wei China 18 351 1.0× 405 1.6× 326 1.4× 76 0.4× 69 0.5× 32 851
Rongying Zhu China 15 460 1.3× 305 1.2× 409 1.7× 107 0.5× 85 0.6× 34 1.0k

Countries citing papers authored by Kin Man Au

Since Specialization
Citations

This map shows the geographic impact of Kin Man Au's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kin Man Au with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kin Man Au more than expected).

Fields of papers citing papers by Kin Man Au

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kin Man Au. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kin Man Au. The network helps show where Kin Man Au may publish in the future.

Co-authorship network of co-authors of Kin Man Au

This figure shows the co-authorship network connecting the top 25 collaborators of Kin Man Au. A scholar is included among the top collaborators of Kin Man Au based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kin Man Au. Kin Man Au is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Au, Kin Man, et al.. (2024). Multiple sclerosis treatments a review of current biomedical engineering approaches. Biomaterials. 313. 122807–122807. 5 indexed citations
3.
Au, Kin Man, Justin E. Wilson, Jenny P.-Y. Ting, & Andrew Z. Wang. (2023). An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis. Nature Biomedical Engineering. 8(10). 1243–1265. 7 indexed citations
4.
Hagan, C. Tilden, Xi Tian, Feifei Yang, et al.. (2021). Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models. Acta Biomaterialia. 124. 327–335. 54 indexed citations
5.
Au, Kin Man, Roland Tisch, & Andrew Z. Wang. (2021). Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen‐Specific Therapy for Experimental Autoimmune Encephalomyelitis. Advanced Materials. 34(5). e2107392–e2107392. 14 indexed citations
6.
Au, Kin Man, Yusra B. Medik, Ke Qi, Roland Tisch, & Andrew Z. Wang. (2021). Immune Checkpoint‐Bioengineered Beta Cell Vaccine Reverses Early‐Onset Type 1 Diabetes. Advanced Materials. 33(25). e2101253–e2101253. 19 indexed citations
7.
Au, Kin Man, Steven Park, & Andrew Z. Wang. (2020). Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy. Science Advances. 6(27). eaba8564–eaba8564. 89 indexed citations
8.
Au, Kin Man, Andrew Z. Wang, & Steven Park. (2020). Pretargeted delivery of PI3K/mTOR small-molecule inhibitor–loaded nanoparticles for treatment of non-Hodgkin’s lymphoma. Science Advances. 6(14). eaaz9798–eaaz9798. 45 indexed citations
10.
Au, Kin Man, Ashutosh Tripathy, Kyle Wagner, et al.. (2018). Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma. ACS Nano. 12(2). 1544–1563. 46 indexed citations
12.
Hagan, C. Tilden, Xi Tian, Feifei Yang, et al.. (2018). Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models. Biomaterials. 169. 1–10. 70 indexed citations
13.
Tian, Jing, Yuanzeng Min, Zachary L. Rodgers, et al.. (2017). Co-delivery of paclitaxel and cisplatin with biocompatible PLGA–PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models. Journal of Materials Chemistry B. 5(30). 6049–6057. 48 indexed citations
14.
Au, Kin Man, Andrew Satterlee, Yuanzeng Min, et al.. (2015). Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic. Biomaterials. 82. 178–193. 118 indexed citations
15.
Caster, Joseph M., Manish Sethi, Edina C. Wang, et al.. (2015). Nanoparticle delivery of chemosensitizers improve chemotherapy efficacy without incurring additional toxicity. Nanoscale. 7(6). 2805–2811. 30 indexed citations
17.
Kasaragod, Deepa, Kin Man Au, Zenghai Lu, et al.. (2013). Photothermal detection of the contrast properties of polypyrrole nanoparticles using optical coherence tomography. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 8596. 85960R–85960R. 3 indexed citations
18.
Au, Kin Man, Zenghai Lu, Stephen J. Matcher, & Steven P. Armes. (2013). Anti-biofouling conducting polymer nanoparticles as a label-free optical contrast agent for high resolution subsurface biomedical imaging. Biomaterials. 34(35). 8925–8940. 17 indexed citations
20.
Au, Kin Man, Zenghai Lu, Stephen J. Matcher, & Steven P. Armes. (2011). Polypyrrole Nanoparticles: A Potential Optical Coherence Tomography Contrast Agent for Cancer Imaging. Advanced Materials. 23(48). 5792–5795. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026